- Nicola Wilck
(Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin
Charité-Universitätsmedizin Berlin
Max-Delbrück Center for Molecular Medicine in the Helmholtz Association
DZHK (German Centre for Cardiovascular Research))
- Mariana G. Matus
(Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology
Computational and Systems Biology Program, Massachusetts Institute of Technology)
- Sean M. Kearney
(Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology)
- Scott W. Olesen
(Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology)
- Kristoffer Forslund
(European Molecular Biology Laboratory, Structural and Computational Biology Unit)
- Hendrik Bartolomaeus
(Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin
Charité-Universitätsmedizin Berlin
Max-Delbrück Center for Molecular Medicine in the Helmholtz Association
DZHK (German Centre for Cardiovascular Research))
- Stefanie Haase
(Friedrich-Alexander-University Erlangen-Nuremberg)
- Anja Mähler
(Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin
Berlin Institute of Health (BIH))
- András Balogh
(Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin
Charité-Universitätsmedizin Berlin
Max-Delbrück Center for Molecular Medicine in the Helmholtz Association
DZHK (German Centre for Cardiovascular Research))
- Lajos Markó
(Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin
Charité-Universitätsmedizin Berlin
Max-Delbrück Center for Molecular Medicine in the Helmholtz Association
DZHK (German Centre for Cardiovascular Research))
- Olga Vvedenskaya
(Max-Delbrück Center for Molecular Medicine in the Helmholtz Association
Integrative Proteomics and Metabolomics Platform, Berlin Institute for Medical Systems Biology BIMSB
Berlin School of Integrative Oncology, Charité University Medicine Berlin)
- Friedrich H. Kleiner
(Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin)
- Dmitry Tsvetkov
(Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin
Charité-Universitätsmedizin Berlin)
- Lars Klug
(Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin
Berlin Institute of Health (BIH))
- Paul I. Costea
(European Molecular Biology Laboratory, Structural and Computational Biology Unit)
- Shinichi Sunagawa
(European Molecular Biology Laboratory, Structural and Computational Biology Unit
Institute of Microbiology, ETH Zurich)
- Lisa Maier
(European Molecular Biology Laboratory, Genome Biology Unit)
- Natalia Rakova
(Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin
Friedrich-Alexander-University Erlangen-Nuremberg)
- Valentin Schatz
(Institute of Clinical Microbiology and Hygiene, University Hospital of Regensburg, University of Regensburg)
- Patrick Neubert
(Institute of Clinical Microbiology and Hygiene, University Hospital of Regensburg, University of Regensburg)
- Christian Frätzer
(Lipidomix GmbH)
- Alexander Krannich
(Berlin Institute of Health (BIH))
- Maik Gollasch
(Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin
Charité-Universitätsmedizin Berlin
Max-Delbrück Center for Molecular Medicine in the Helmholtz Association)
- Diana A. Grohme
(Translational Immunology, Medical Faculty Carl Gustav Carus, Technical University of Dresden)
- Beatriz F. Côrte-Real
(VIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research (IRC), Hasselt University, Campus Diepenbeek)
- Roman G. Gerlach
(Project Group 5, Robert Koch Institute)
- Marijana Basic
(Hannover Medical School, Institute for Laboratory Animal Science and Central Animal Facility)
- Athanasios Typas
(European Molecular Biology Laboratory, Genome Biology Unit)
- Chuan Wu
(Experimental Immunology Branch, National Cancer Institute, US National Institutes of Health)
- Jens M. Titze
(Vanderbilt University School of Medicine)
- Jonathan Jantsch
(Institute of Clinical Microbiology and Hygiene, University Hospital of Regensburg, University of Regensburg)
- Michael Boschmann
(Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin
Berlin Institute of Health (BIH))
- Ralf Dechend
(Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin
Charité-Universitätsmedizin Berlin
Berlin Institute of Health (BIH))
- Markus Kleinewietfeld
(Translational Immunology, Medical Faculty Carl Gustav Carus, Technical University of Dresden
VIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research (IRC), Hasselt University, Campus Diepenbeek
Center for Regenerative Therapies Dresden (CRTD))
- Stefan Kempa
(Max-Delbrück Center for Molecular Medicine in the Helmholtz Association
Berlin Institute of Health (BIH)
Integrative Proteomics and Metabolomics Platform, Berlin Institute for Medical Systems Biology BIMSB)
- Peer Bork
(Max-Delbrück Center for Molecular Medicine in the Helmholtz Association
European Molecular Biology Laboratory, Structural and Computational Biology Unit
Molecular Medicine Partnership Unit, University of Heidelberg and European Molecular Biology Laboratory
Biocenter, University of Würzburg)
- Ralf A. Linker
(Friedrich-Alexander-University Erlangen-Nuremberg)
- Eric J. Alm
(Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology)
- Dominik N. Müller
(Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin
Charité-Universitätsmedizin Berlin
Max-Delbrück Center for Molecular Medicine in the Helmholtz Association
DZHK (German Centre for Cardiovascular Research))